In the wake of a controversy over unsafe capsules in China, the State Food and Drug Administration may blacklist some pharmaceutical manufacturers. The move is seen as an effort to restore a degree of public confidence after the SFDA conducted a month-long probe and found that 254 pharmaceutical companies, or 12.7 percent of all capsule makers, turned out capsules containing unsafe levels of chromium (back story).
The investigation, however, was begun only after local media uncovered the problem. And so the SFDA is floating the blacklist proposal and soliciting public comments until next Wednesday, according to China Daily. The blacklist will contain companies and people that “severely” violate safety rules in manufacturing and selling medicine and medical equipment (here is the SFDA statement).
http://www.pharmalot.com/2012/06/china-may-blacklist-unsavory-capsule-makers/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Pharmalot+%28Pharmalot%29&utm_content=Google+Reader
No comments:
Post a Comment